deltatrials
Unknown PHASE2 INTERVENTIONAL 2-arm NCT05492487

A Pilot Study on Fertility Conservative Treatment of Atypical Endometrial Hyperplasia in Singapore

Sponsor: KK Women's and Children's Hospital

Conditions Disease Regression Endometrial Hyperplasia Fertility Issues Treatment Side Effects
Interventions Megace Mirena
Updated 3 times since 2022 Last updated: Aug 5, 2022 Started: Jan 3, 2020 Primary completion: Mar 31, 2023 Completion: Mar 31, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Disease Regression and Endometrial Hyperplasia and is currently ongoing. KK Women's and Children's Hospital leads this study, which shows 3 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Sep 2022 – ~Jul 2024 · 22 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshotUnknown

Change History

3 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE2

    Status: Recruiting → Unknown

  2. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE2

  3. Sep 2022 — Jul 2024 [monthly]

    Recruiting PHASE2

    First recorded

Jan 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • KK Women's and Children's Hospital
Data source: KK Women's and Children's Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations